Tumor targeting with a 99mTc-labeled AS1411 aptamer in prostate tumor cells

Journal of Drug Targeting

Volumn 23, Issue 6, 2015, Pages 497-505

  Noaparast, Zohreh ^a   Hosseinimehr, Seyed Jalal ^a   Piramoon, Majid ^a   Abedi, Seyed Mohammad ^b  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

99mTc; aptamer; AS1411; nucleolin; targeting; tumor

Indexed keywords

APTAMER; AS1411 APTAMER TC 99M; NUCLEOLIN; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; UNCLASSIFIED DRUG; 6-HYDRAZINOPYRIDINE-3-CARBOXYLIC ACID; AGRO 100; HYDRAZINE DERIVATIVE; NICOTINIC ACID DERIVATIVE; OLIGODEOXYRIBONUCLEOTIDE; PHOSPHOPROTEIN; RNA BINDING PROTEIN; TECHNETIUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BINDING; DRUG CONJUGATION; DRUG PURITY; DRUG STABILITY; DRUG TARGETING; GEL PERMEATION CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROSTATE TUMOR; RADIOACTIVITY; RADIOCHEMISTRY; THIN LAYER CHROMATOGRAPHY; TUMOR CELL; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; METABOLISM; PROCEDURES; RADIOASSAY; SCINTISCANNING; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; APTAMERS, NUCLEOTIDE; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; HUMANS; HYDRAZINES; MALE; MICE; NICOTINIC ACIDS; OLIGODEOXYRIBONUCLEOTIDES; ORGANOTECHNETIUM COMPOUNDS; PHOSPHOPROTEINS; PROSTATIC NEOPLASMS; RADIOLIGAND ASSAY; RNA-BINDING PROTEINS; TISSUE DISTRIBUTION;

EID: 84938581822     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2015.1009075     Document Type: Article

References (41)

1. Derenzini M, Sirri V, Trere D, et al. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab Invest 1995; 73: 497-502
2. Kotula JW, Pratico ED, Ming X, et al. Aptamer-mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells. Nucleic Acid Ther 2012; 22: 187-95
3. Lai P-S, Pai C-L, Hsu C-Y, et al. As1411 aptamer conjugated polymeric micelle for targetable cancer therapy. NSTI-Nanotech 2010; 3: 330-3
4. Xu X, Hamhouyia F, Thomas SD, et al. Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides. J Biol Chem 2001; 276: 43221-30
5. Essink-Bot ML, de Koning HJ, Nijs HG, et al. Short-term effects of population-based screening for prostate cancer on health-related quality of life. J Natl Cancer Inst 1998; 90: 925-31
6. Schenk JM, Kristal AR, Arnold KB, et al. Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial. Am J Epidemiol 2011; 173: 1419-28
7. Brakenhielm E, Burton JB, Johnson M, et al. Modulating metastasis by a lymphangiogenic switch in prostate cancer. Int J Cancer 2007; 121: 2153-61
8. Foss CA, Mease RC, Fan H, et al. Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer. Clin Cancer Res 2005; 11: 4022-8
9. Ni X, Castanares M, Mukherjee A, et al. Nucleic acid aptamers: clinical applications and promising new horizons. Curr Med Chem 2011; 18: 4206-14
10. Ray P, White RR. Aptamers for targeted drug delivery. Pharmaceuticals 2010; 3: 1761-78
11. Gao H, Yang Z, Zhang S, et al. Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays. Acta Biomater 2014; 10: 858-67
12. Christian S, Pilch J, Akerman ME, et al. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol 2003; 163: 871-8
13. Ko MH, Kim S, Kang WJ, et al. In vitro derby imaging of cancer biomarkers using quantum dots. Small 2009; 5: 1207-12
14. Lee KY, Kang H, Ryu SH, et al. Bioimaging of nucleolin aptamer-containing 5-(N -benzylcarboxyamide)-2′-deoxyuridine more capable of specific binding to targets in cancer cells. J Biomed Biotechnol 2010; 2010: 168306
15. Gao H, Qian J, Cao S, et al. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials 2012; 33: 5115-23
16. Gao H, Yang Z, Zhang S, et al. Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles. J Drug Target 2014; 22: 450-9
17. Bates PJ, Laber DA, Miller DM, et al. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp Mol Pathol 2009; 86: 151-64
18. Bishop JS, Guy-Caffey JK, Ojwang JO, et al. Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide. J Biol Chem 1996; 271: 5698-703
19. Dapic V, Bates PJ, Trent JO, et al. Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications. Biochemistry 2002; 41: 3676-85
20. Bates PJ, Kahlon JB, Thomas SD, et al. Antiproliferative activity of G-rich oligonucleotides correlates with protein binding. J Biol Chem 1999; 274: 26369-77
21. Kurabachew M, Wondimu A, Ryon JJ, et al. Reverse transcription-PCR detection of Mycobacterium leprae in clinical specimens. J Clin Microbiol 1998; 36: 1352-6
22. Li J, Trent JO, Bates PJ, et al. Factors affecting the labeling yield of F-18-labeled AS1411. J Label Compd Radiopharm 2007; 50: 1255-9
23. Cibiel A, Pestourie C, Duconge F, et al. In vivo uses of aptamers selected against cell surface biomarkers for therapy and molecular imaging. Biochimie 2012; 94: 1595-606
24. Shangguan D, Li Y, Tang Z, et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA 2006; 103: 11838-43
25. Soundararajan S, Chen W, Spicer EK, et al. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res 2008; 68: 2358-65
26. Rosenberg JE, Bambury RM, Van Allen EM, et al. A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma. Invest New Drugs 2014; 32: 178-87
27. Hwang do W, Ko HY, Lee JH, et al. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J Nucl Med 2010; 51: 98-105
28. Li J, Zheng H, Bates PJ, et al. Aptamer imaging with Cu-64 labeled AS1411: preliminary assessment in lung cancer. Nucl Med Biol 2014; 41: 179-85
29. Varmira K, Hosseinimehr SJ, Noaparast Z, et al. An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers. J Drug Target 2014; 22: 116-22
30. Girvan AC, Teng Y, Casson LK, et al. AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin. Mol Cancer Ther 2006; 5: 1790-9
31. Hernandez LI, Flenker KS, Hernandez FJ, et al. Methods for evaluating cell-specific, cell-internalizing rna aptamers. Pharmaceuticals (Basel) 2013; 6: 295-319
32. Hicke BJ, Stephens AW, Gould T, et al. Tumor targeting by an aptamer. J Nucl Med 2006; 47: 668-78
33. Kuhnast B, Dolle F, Terrazzino S, et al. General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies. Bioconjug Chem 2000; 11: 627-36
34. McMicken HW, Bates PJ, Chen Y, et al. Antiproliferative activity of G-quartet-containing oligonucleotides generated by a novel single-stranded DNA expression system. Cancer Gene Ther 2003; 10: 867-9
35. Sen D, Gilbert W. Guanine quartet structures. Methods Enzymol 1992; 211: 191-9
36. Bock LC, Griffin LC, Latham JA, et al. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 1992; 355: 564-6
37. Jing N, De Clercq E, Rando RF, et al. Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors. A basis for anti-HIV drug design. J Biol Chem 2000; 275: 3421-30
38. Rando RF, Ojwang J, Elbaggari A, et al. Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular tetrads. J Biol Chem 1995; 270: 1754-60
39. Teng Y, Girvan AC, Casson LK, et al. AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin. Cancer Res 2007; 67: 10491-500
40. Varmira K, Hosseinimehr SJ, Noaparast Z, et al. A HER2-targeted RNA aptamer molecule labeled with 99mTc for single-photon imaging in malignant tumors. Nucl Med Biol 2013; 40: 980-6
41. Hosseinimehr SJ, Tolmachev V, Orlova A, et al. Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design. Drug Discov Today 2012; 17: 1224-32